Our Approach

Many inherited metabolic liver diseases such as Wilson's disease, Gaucher's disease, lipidosis, alpha-1 antitrypsin deficiency, hemochromatosis, tyrosinemia, and glycogen storage diseases are cured by successful liver transplantation. We specialize in genetic testing for liver diseases and treatments that provide comprehensive care for affected patients. Even though we treat some of the most seriously ill patients, our program's survival rates are consistently higher than the national average.

We offer many options for advanced liver disease, including living donor and deceased donor transplantation, liver transplantation in HIV-infected individuals, and pre- and post-transplant antiviral therapy to prevent or treat recurrent hepatitis C.

Through our acute liver failure program, we can transfer patients to Yale New Haven Hospital in a timely manner for transplant evaluation and medical management. In collaboration with the hospital’s Medical Intensive Care Unit, we offer innovative techniques such as hypothermia therapy for the treatment of acute liver failure.

Pancreatic transplants are less common than kidney or liver transplants and are usually performed in patients with type 1 diabetes. Our physicians perform isolated pancreas transplantation, simultaneous kidney/pancreas transplantation, and pancreas transplantation following kidney transplantation.

Specialized care is offered in the following areas:

• Combined organ transplantation including kidney, kidney/liver, and kidney/heart
• Comprehensive tissue typing and immune evaluation services
• Follow-up and psychosocial support
• Leading-edge treatment options for immunosuppression
• Liver transplantation, including adult-to-adult living donor, pediatric living donor, and other surgeries
• Minimally invasive living-donor kidney surgeries
• Robotic hepatobiliary surgery
• Surgical therapy of diseases of the liver and biliary systems and end-stage kidney and liver disease
• Telemedicine via patient portal